Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025

Introduction

The Cleveland Clinic Heart Failure Summit: Expanding the Frontiers of Contemporary Team Management 2025 is an advanced cardiovascular education program focused on modern multidisciplinary management of heart failure across the continuum of care. Presented by Cleveland Clinic, the course delivers practical and evidence-based updates in pharmacologic therapy, device management, electrophysiology, cardiomyopathy care, and advanced heart failure interventions.

The curriculum emphasizes contemporary team-based cardiovascular care while integrating:

• Guideline-directed heart failure therapy
• HFrEF and HFpEF management
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• Electrophysiology in heart failure
• Sudden cardiac death prevention
• Mechanical and surgical therapies
• Novel pharmacologic interventions
• Advanced cardiovascular therapeutics
• Multidisciplinary heart failure management

into a clinically practical educational experience designed to improve outcomes for complex heart failure patients.

Course Overview

📚 Program: Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025

🏛️ Presented by Cleveland Clinic

🎥 Included Content

• 7 video lectures
• 38 PDF presentations

💾 Course Size: 2.21 GB

🎓 Educational Format

• Expert-led cardiovascular lectures
• Guideline-focused education
• Advanced heart failure reviews
• Case-based clinical discussions
• Multidisciplinary management strategies

The course is designed to provide practical updates in contemporary heart failure care and advanced cardiovascular management.

Educational Focus

The program focuses on:

• Advanced heart failure management
• HFrEF and HFpEF therapies
• Novel cardiovascular pharmacology
• Device-based heart failure interventions
• Cardiac electrophysiology
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• Sudden cardiac death prevention
• Multidisciplinary cardiovascular care
• Team-based heart failure management

The curriculum integrates evidence-based medicine with clinically practical therapeutic strategies.

Learning Objectives

After completing this activity, learners strengthen their ability to:

• Optimize use of current and novel heart failure therapies for reduced ejection fraction
• Differentiate reduced versus preserved ejection fraction heart failure phenotypes
• Apply advanced medical devices and surgical therapies in heart failure care
• Discuss emerging therapies for HFmrEF and HFpEF
• Employ contemporary management strategies for cardiac amyloidosis and hypertrophic cardiomyopathy
• Identify electrophysiologic interventions for atrial arrhythmias and sudden cardiac death prevention
• Improve multidisciplinary coordination in advanced cardiovascular care

The educational material emphasizes modern guideline-directed management and practical clinical implementation.

Heart Failure Pharmacologic Management

A major educational component focuses on optimization of medical therapy in heart failure.

Covered Areas

• Guideline-directed medical therapy (GDMT)
• Novel heart failure pharmacology
• HFrEF treatment optimization
• HFmrEF management
• HFpEF therapies
• Advanced pharmacologic strategies
• Contemporary evidence-based drug therapy

The curriculum reviews current and emerging therapies designed to improve outcomes in chronic heart failure.

Heart Failure Phenotypes & Clinical Profiles

Dedicated sessions review the clinical spectrum of heart failure syndromes.

Topics Include

• Reduced ejection fraction heart failure
• Preserved ejection fraction heart failure
• Midrange ejection fraction heart failure
• Clinical phenotyping strategies
• Diagnostic differentiation
• Hemodynamic and structural considerations

Participants strengthen practical understanding of diverse heart failure presentations and treatment approaches.

Device Therapy & Surgical Interventions

The course reviews modern procedural and surgical options in advanced heart failure care.

Educational Topics

• Implantable cardiac devices
• Cardiac resynchronization therapy
• Defibrillator therapy
• Surgical heart failure interventions
• Mechanical circulatory support concepts
• Device-based management strategies

The sessions emphasize practical integration of procedural therapies into comprehensive cardiovascular care.

Cardiac Amyloidosis & Hypertrophic Cardiomyopathy

Specialized lectures focus on infiltrative and structural cardiomyopathies.

Covered Areas

• Cardiac amyloidosis recognition and management
• Hypertrophic cardiomyopathy therapeutics
• Advanced cardiomyopathy evaluation
• Imaging and diagnostic strategies
• Disease-specific management principles

The curriculum highlights emerging therapies and modern approaches to complex myocardial disease.

Electrophysiology & Arrhythmia Management

A major educational focus involves rhythm management in heart failure patients.

Topics Include

• Sudden cardiac death prevention
• Atrial arrhythmia management
• Electrophysiologic interventions
• Rhythm-control strategies
• Device therapy integration
• Arrhythmia risk reduction

Participants gain practical understanding of electrophysiologic approaches in advanced cardiovascular disease.

Team-Based Heart Failure Care

The course strongly emphasizes multidisciplinary cardiovascular management.

Educational Themes

• Integrated heart failure programs
• Collaborative patient management
• Multidisciplinary cardiovascular teams
• Coordinated chronic disease care
• Comprehensive patient-centered strategies

The program highlights the importance of collaborative care models in improving long-term outcomes.

Educational Experience

The summit combines:

• Expert-led cardiovascular lectures
• Evidence-based therapeutic reviews
• Advanced heart failure updates
• Practical management strategies
• Case-based discussions
• Multidisciplinary cardiovascular education

The educational structure emphasizes clinically applicable learning for contemporary heart failure practice.

Why This Course Stands Out

Contemporary Heart Failure Focus

Provides advanced review of modern pharmacologic and procedural heart failure therapies.

Multidisciplinary Team Management

Highlights integrated cardiovascular care models and collaborative management strategies.

Advanced Cardiomyopathy Education

Includes specialized coverage of cardiac amyloidosis and hypertrophic cardiomyopathy.

Strong Electrophysiology Integration

Reviews arrhythmia management and sudden cardiac death prevention in heart failure populations.

Practical Clinical Application

Emphasizes evidence-based therapies directly applicable to daily cardiovascular practice.

Clinical Value

The Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025 delivers advanced cardiovascular education through integrated coverage of:

• HFrEF management
• HFpEF and HFmrEF therapies
• Novel heart failure pharmacology
• Device-based interventions
• Cardiac electrophysiology
• Sudden cardiac death prevention
• Cardiac amyloidosis
• Hypertrophic cardiomyopathy
• Surgical heart failure therapies
• Multidisciplinary cardiovascular management
• Advanced heart failure care
• Evidence-based therapeutic strategies

The combination of expert-led instruction, multidisciplinary clinical education, and contemporary therapeutic updates makes this summit highly valuable for clinicians managing complex heart failure patients.

Topics:

Saturday, May 17, 2025

• 6:45 a.m. Registration, Breakfast & View Exhibits
• 7–7:55 a.m. Non-CME Breakfast Symposium Hosted by AstraZeneca
• 7:55 a.m. Welcome & Introductions David Cork, MD and Christopher Suhar, MD
• 8 a.m. LDL-Cholesterol: Ideal Targets. How Low is too Low? Nicholas Marston, MD
• 8:30 a.m. Non-Statin Therapies: Deep Dive Pam Taub, MD
• 9 a.m. Cardiometabolic Health: The Risk of Obesity and Pharmacotherapy Review Lauren Vincent, MD
• 9:30 a.m. Panel Discussion/Q&A
• 9:45 a.m. Break & View Exhibits
• 10:15 a.m. Resistant Hypertension Management: Current and Future Pharmacotherapies and Renal Denervation David Cork, MD
• 10:45 a.m. Diagnostic Testing for Obstructive CAD: Which Modality to Choose? Matthew Budoff, MD
• 11:15 a.m. Cardiovascular Disease in Women: An Update Martha Gulati, MD
• 11:45 a.m. Panel Discussion/Q&A
• Noon Non-CME Lunch Symposium Hosted by Novartis Pharmaceuticals Little Particle, Big Impact: Exploring Lp(a) From a Perspective of a Patient With a Premature ASCVD Event Dan Luu, PharmD, BCPS
• 1 p.m. Atrial Fibrillation Management: Introducing Pulsed Field Ablation Nicholas Olson, MD
• 1:30 p.m. Atrial Fibrillation Management: Anticoagulation or Left Atrial Appendage Occlusion? Douglas Gibson, MD
• 2 p.m. Diet and Exercise: Counsel Your Patients More Effectively Christopher Suhar, MD
• 2:30 p.m. Panel Discussion/Q&A
• 2:45 p.m. Break & View Exhibits
• 3 p.m. The Best Biomarkers to Assess Atherosclerotic Risk P. Barton Duell, MD
• 3:30 p.m. Peripheral Artery Disease Update Curtiss Stinis, MD
• 4 p.m. Diagnostic Evaluation and Management of Coronary Vasospasm and Endothelial Dysfunction Matthew Price, MD
• 4:30 p.m. Panel Discussion/Q&A
• 4:45 p.m. Adjourn Topics, times, and speakers are subject to change.